Retatrutide Next Generation GLP-1 Peptide EXPLAINED
Retatrutide could become the most powerful weight-loss drug yet, and it may push obesity treatment into completely new territory. Unlike Ozempic and Wegovy, which primarily target GLP-1, Retatrutide activates three hormone pathways at once: GLP-1, GIP, and glucagon. That combination is what makes it different.GLP-1 suppresses appetite. GIP helps regulate how the body processes incoming energy. And glucagon may push the body toward releasing stored fuel rather than simply consuming less of it. The results have attracted enormous attention.
Clinical trials have reported average weight loss approaching 30% of total body weight at the highest doses-levels that begin to resemble outcomes traditionally associated with bariatric surgery. But Retatrutide is still investigational.
Researchers are continuing to study its long-term safety, including effects on heart rate, muscle loss, and neurological symptoms such as dysesthesia.
Meanwhile, unapproved versions are already being sold online, despite having no legitimate quality control or guarantee that the vial contains what the label claims. That creates two very different stories.
Inside controlled clinical trials, Retatrutide could represent a major advance in metabolic medicine. Outside them, it becomes an uncontrolled experiment.
So is Retatrutide really the “King Kong” of weight-loss drugs? The early data is extraordinary, but the safety story is still being written.
01:37 - How Ozempic Changed the Science of Obesity
05:16 - Why Retatrutide Targets Three Hormones at Once
08:01 - How Retatrutide Forces the Body to Burn Fat
13:27 - The Gila Monster Discovery Behind GLP-1 Drugs
17:22 - The Billion-Dollar Race Between Novo Nordisk and Eli Lilly
18:33 - The Clinical Trials That Put Retatrutide Ahead
21:29 - Heart Risks, Muscle Loss and New Side Effects
23:59 - The Dangerous Gray Market for Unapproved Retatrutide
Narrated by: Josh Risser
🔔 Don't forget to SUBSCRIBE! 🔔
SUGGEST A TOPIC: https://bit.ly/suggest-an-infographics-video
💬 Come chat with me: https://discord.gg/theinfoshow
🔖 MY SOCIAL PAGES
TikTok ► https://www.tiktok.com/@theinfographicsshow
Facebook ► https://www.facebook.com/TheInfographicsShow
📝 SOURCES: https://pastebin.com/ZhXW51Wd
All videos are based on publicly available information unless otherwise noted. Receive SMS online on sms24.me
TubeReader video aggregator is a website that collects and organizes online videos from the YouTube source. Video aggregation is done for different purposes, and TubeReader take different approaches to achieve their purpose.
Our try to collect videos of high quality or interest for visitors to view; the collection may be made by editors or may be based on community votes.
Another method is to base the collection on those videos most viewed, either at the aggregator site or at various popular video hosting sites.
TubeReader site exists to allow users to collect their own sets of videos, for personal use as well as for browsing and viewing by others; TubeReader can develop online communities around video sharing.
Our site allow users to create a personalized video playlist, for personal use as well as for browsing and viewing by others.
@YouTubeReaderBot allows you to subscribe to Youtube channels.
By using @YouTubeReaderBot Bot you agree with YouTube Terms of Service.
Use the @YouTubeReaderBot telegram bot to be the first to be notified when new videos are released on your favorite channels.
Look for new videos or channels and share them with your friends.
You can start using our bot from this video, subscribe now to Retatrutide Next Generation GLP-1 Peptide EXPLAINED
What is YouTube?
YouTube is a free video sharing website that makes it easy to watch online videos. You can even create and upload your own videos to share with others. Originally created in 2005, YouTube is now one of the most popular sites on the Web, with visitors watching around 6 billion hours of video every month.
